Results 151 to 160 of about 106,006 (259)

Isolation and radioimmunoassay of thyroxine-binding globulin (TGB) [PDF]

, 1974
Erhardt, F., Horn, K., Livesey, P. G., Scriba, Peter Christian   +3 more
core   +1 more source

Thyroxine Levels During Pregnancy in Healthy Women and Early Child Neurodevelopment

Epidemiology, 2013
J. Júlvez, M. Álvarez-Pedrerol, M. Rebagliato, M. Murcia, J. Forns, R. Garcia-Esteban, N. Lertxundi, M. Espada, A. Tardón, Isolina Riaño Galán, J. Sunyer   +10 more
semanticscholar   +1 more source

Reduced cardiovascular mortality at moderate altitude: a putative role of physical activity and body mass

The Journal of Physiology, EarlyView.
Abstract figure legend Benefits of performing physical exercise at moderate altitude. At moderate altitude, increased resting metabolic rate and physical exertion promote physical fitness and exercise tolerance, whereas hypoxia suppresses appetite and elicits adaptations that increase tissue O2 delivery while augmenting O2‐independent ATP production ...
Robert T. Mallet, Johannes Burtscher, Hannes Gatterer, Katharina Hüfner, Samuel Verges, Tadej Debevec, Martin Burtscher   +6 more
wiley   +1 more source

Thyroxine treatment: absorption, malabsorption, and novel therapeutic approaches

Endocrine, 2013
M. Centanni
semanticscholar   +1 more source

Validation of Immunoassays for Total Thyroxine and Free Thyroxine and Age and Sex‐Related Variation in Thyroid Hormone Serum Concentrations in Orangutans (Pongo sp.)

Journal of Medical Primatology, Volume 55, Issue 3, June 2026.
ABSTRACT Background Thyroid disease is reported in orangutans, but to properly diagnose and manage these disorders, reference intervals for circulating thyroid hormones are needed. Methods Commercial immunoassay kits for total thyroxine (TT4) and free thyroxine (FT4) were validated for use in orangutans (Pongo spp.).
Melissa A. Fayette, Anneke Moresco, Enass Bassiouny, Dalen W. Agnew, Brian Petroff   +4 more
wiley   +1 more source

Papillary Thyroid Carcinoma Originating in a Male With Thyroglossal Duct Cyst: Case Presentation and Literature Review

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Papillary carcinoma arising in a thyroglossal duct cyst is rare and often indistinguishable from benign disease. We report a male patient with progressive cyst changes leading to diagnosis and successful Sistrunk‐based management, highlighting the need for close, appropriate imaging and individualized treatment in midline neck masses.
Nasim Abukaresh, Hossam Salameh, Tala Dweik, Anan Dawadi, Haya Taha, Sohaib Salahat, Ahmed Aljodi   +6 more
wiley   +1 more source

Psychological well‐being in patients on ‘adequate’ doses of l‐thyroxine: results of a large, controlled community‐based questionnaire study

Clinical Endocrinology, 2002
P. Saravanan, W. Chau, N. Roberts, K. Vedhara, R. Greenwood, C. Dayan   +5 more
semanticscholar   +1 more source

An Evaluation of Longitudinal Thyroid Hormone Levels Over the Years Before and After Patients Started on Levothyroxine

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
Free thyroxine (FT4) median (interquartile range) and percentage FT4 within reference range for patients pre‐ and post‐levothyroxine (LT4) treatment versus untreated individuals. ABSTRACT Introduction This retrospective study aimed to investigate how free thyroxine (FT4) and thyroid‐stimulating hormone (TSH) levels change in the years pre‐ and post ...
Michael Stedman, Peter Taylor, Ian Halsall, David Halsall, Buchi Okosieme, Suhani Bahl, Sangeeth Veluchamy, Lakdasa Premawardhana, Anthony A. Fryer, Colin Dayan, Adrian Heald   +10 more
wiley   +1 more source

The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial.

Journal of Clinical Endocrinology and Metabolism, 2007
S. Razvi, L. Ingoe, G. Keeka, C. Oates, C. McMillan, J. Weaver   +5 more
semanticscholar   +1 more source

Comparative Efficacy and Safety of Resmetirom and Efruxifermin for Metabolic Dysfunction‐Associated Steatohepatitis: A Network Meta‐Analysis of Randomized Controlled Trials

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
This meta‐analysis compared Resmetirom and Efruxifermin in patients with MASH, focusing on improvements in key biochemical and non‐invasive markers. Efruxifermin is associated with favourable outcomes with a slightly greater effect on MRI‐PDFF and AST, along with more comparable safety outcomes.
Doha Jaber, Inas Jaber, Ayah Abu Lehia, Thekrayat Asad, Hazem Ayesh   +4 more
wiley   +1 more source